HC Wainwright & Co. Maintains Buy on Equillium, Lowers Price Target to $4.5
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Raghuram Selvaraju has maintained a Buy rating on Equillium (NASDAQ:EQ) but has reduced the price target from $5.5 to $4.5.
November 13, 2023 | 4:25 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Equillium's Buy rating is maintained by HC Wainwright & Co., but the price target is lowered from $5.5 to $4.5.
The reduction in the price target by HC Wainwright & Co. suggests a less optimistic valuation of Equillium's stock, which could lead to a negative short-term impact on the stock price as investors adjust their expectations.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100